<p>Jazz Pharmaceuticals plc has filed an initial statement of beneficial ownership (Form 3) with the U.S. Securities and Exchange Commission. The filing lists Ted W. Love as a director of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001188919-25-000006), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

JAZZ

<p>Jazz Pharmaceuticals has filed an initial statement of beneficial ownership (Form 3) with the U.S. SEC, listing Ted W. Love as a director. The filing is available via EDGAR. This news brief was created by Public Technologies using AI and is for informational purposes only.</p>

Jazz Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Ted W. Love